Eric Raffin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way, Dover, NH 03820 Phone: 603-742-1444 |
Dr. Sandy Chin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way, Suite 402, Dover, NH 03820 Phone: 603-742-1444 Fax: 603-742-1443 |
Egbert D Baumgart, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 17 Old Rollinsford Road, Suite 3, Dover, NH 03820 Phone: 608-742-5011 Fax: 603-742-3530 |
Dr. Shilpa Lamba, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way, Suite 402, Dover, NH 03820 Phone: 603-742-1444 Fax: 603-742-1443 |
News Archive
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells.
A group of "professional couch potatoes," as one researcher described them, has proven that even moderate exercise - in this case walking at one's own pace for 40 minutes three times a week - can enhance the connectivity of important brain circuits, combat declines in brain function associated with aging and increase performance on cognitive tasks.
ARIAD Pharmaceuticals, Inc. today announced that the European Commission has granted a marketing authorization for Iclusig (ponatinib) as an orphan medicinal product for two indications.
Today, the U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to include adolescents 12 through 15 years of age.
In keeping with the shift in cancer research from data generation to data analysis, bioinformatician W. Jim Zheng, Ph.D., of The University of Texas Health Science Center at Houston has been awarded a five-year, $5.8 million Cancer Prevention & Research Institute of Texas grant to sort out information that could lead to cancer cures.
› Verified 4 days ago